Latest news

June 21, 2002

H3 Pharma announces promising developments for the treatment of Alzheimer´s disease

Read more
May 14, 2002

Debiopharm S.A. reports study revealing that EPI-HNE4 offers protection against acute lung injury

Read more
March 24, 2002

Debiopharm SA a acquis un nouveau bâtiment à Lausanne et projette de déménager vers la fin 2004

Read more
March 17, 2002

H3 Pharma Licenses in Phase II Product for Stomach Cancer and Acquires Stake in a Human mAb Discovery Company Specializing…

Read more
March 12, 2002

Swiss company Debio R.P. announces Agreement with Inhale subsidiary Shearwater Corporation

Read more
July 5, 2001

Swiss drug developer Debiopharm announces FDA approval of Trelstar TM LA for therapeutic use

Read more
June 7, 2001

New pharmaceutical development company in Quebec : The SGF and the Swiss Group Debio create H3 BioDé

Read more
May 19, 2001

Partenariat entre l’Ecole de Pharmacie Genève-Lausanne (EPGL) et Debiopharm Group™ – L’Université et l’Industrie allient leurs forces

Read more
April 14, 2001

Debiopharm and Aurigene sign agreement for the development and commercialisation of Debio 1142, a novel inhibitor of an undisclosed oncology…

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.